The need of a multicomponent guiding approach to personalize clopidogrel treatment-Reference-Cited by-同舟云学术

The need of a multicomponent guiding approach to personalize clopidogrel treatment

Published:2020-10-09 Issue:2 Volume:21 Page:116-127
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Valeria Conti^ORCID,Carmine Sellitto,Valentina Manzo,Teresa Iannaccone,Maria Costantino,Martina Torsiello,Giancarlo Accarino,Giovanna Nicolella,Graziamaria Corbi^ORCID,Amelia Filippelli^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.nature.com/articles/s41397-020-00189-2.pdf

Reference59 articles.

1. Kheiri B, Osman M, Abdalla A, Haykal T, Swaid B, Ahmed S. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials. J Thromb Thrombolysis. 2019;47:233–247.

2. Al-Husein BA, Al-Azzam SI, Alzoubi KH, Khabour OF, Nusair MB, Alzayadeen S. Investigating the effect of demographics, clinical characteristics, and polymorphism of MDR-1, CYP1A2, CYP3A4, and CYP3A5 on clopidogrel resistance. J Cardiovasc Pharmacol. 2018;72:296–302.

3. Manzo V, Tarallo S, Iannaccone T, Costantino M, Filippelli W, Filippelli A. Cardiovascular pharmacogenomics. Curr Pharmacogenomics Personalized Med. 2017;15:1–14.

4. Tcheng JE, Mackay SM. Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients. Am J Cardiovasc Drugs. 2012;12:83–91. 1

5. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57. 10

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the effect of CYP2C19 gene properties on the anti-platelet aggregation of clopidogrel after carotid artery stenting under network pharmacology;BMC Pharmacology and Toxicology;2024-06-06

2. Computational drug–drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel;Future Science OA;2024-05-17

3. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome;Biomedicine & Pharmacotherapy;2023-12

4. Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes;Pharmacogenomics and Personalized Medicine;2023-10

5. Multiple genetic mutations increase the risk of thrombosis associated with clopidogrel after percutaneous coronary intervention;Pharmacogenomics;2023-03